![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
XAIR Beyond Air
- 0.418
- +0.022+5.48%
Close Jan 23 16:00 ET
- 0.416
- -0.002-0.53%
Post 18:41 ET
30.17MMarket Cap-0.30P/E (TTM)
0.435High0.400Low540.41KVolume0.408Open0.396Pre Close223.93KTurnover1.11%Turnover RatioLossP/E (Static)72.19MShares2.17052wk High1.07P/B20.35MFloat Cap0.29652wk Low--Dividend TTM48.70MShs Float16.410Historical High--Div YieldTTM8.83%Amplitude0.296Historical Low0.414Avg Price1Lot Size
Beyond Air Stock Forum
Sign in to post a comment
$Beyond Air (XAIR.US)$ Reuters· 17 mins ago
Advisory- Alert on Beyond Cancer's Clinical Trial Approval Was Incorrectly Tagged to Beyond Air and Is Being Withdrawn
Advisory- Alert on Beyond Cancer's Clinical Trial Approval Was Incorrectly Tagged to Beyond Air and Is Being Withdrawn
7
$Beyond Air (XAIR.US)$
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy
Tuesday, 3rd December at 4:05 pm
• The Phase 1b study will evaluate LV UNO in unresectable cutaneous or subcutaneous histologically confirmed primary or metastatic solid tumor cancer patients that have progressed or have prolonged stable disease on single agent P...
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy
Tuesday, 3rd December at 4:05 pm
• The Phase 1b study will evaluate LV UNO in unresectable cutaneous or subcutaneous histologically confirmed primary or metastatic solid tumor cancer patients that have progressed or have prolonged stable disease on single agent P...
Note: This seems to be a long list. The rationale is that I al focused on at least 20% gains and not just after bangers. My trading style is to compound those 10-15-20-30% earnings and roll all profit rather than waiting for runners everyday. If runners appear, then I’ll grab it as well. Each has his own style earning.
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
35
19
5
$Beyond Air (XAIR.US)$
Beyond Air Receives CE Mark in Europe for the LungFit® PH System
Monday, 2nd December at 7:30 am
Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular function in conjunction with heart surgery
A $1 million milestone payment is triggered from Asia-Pacific partner, Getz Healthcare
Beyond Air Receives CE Mark in Europe for the LungFit® PH System
Monday, 2nd December at 7:30 am
Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular function in conjunction with heart surgery
A $1 million milestone payment is triggered from Asia-Pacific partner, Getz Healthcare
2
$Beyond Air (XAIR.US)$ Revenues increased 17% compared to the previous quarter ended June 30, 2024
Strengthened balance sheet is expected to provide sufficient cash runway through June 2026
Completed a $20.6 million private placement offering with multiple healthcare-focused institutional funds and Company insiders
Retired $17.5 million in debt from Avenue Capital and entered into a $11.5 million loan agreement with an insider-led investor group
Conference call scheduled for 4:30 p.m. ET today...
Strengthened balance sheet is expected to provide sufficient cash runway through June 2026
Completed a $20.6 million private placement offering with multiple healthcare-focused institutional funds and Company insiders
Retired $17.5 million in debt from Avenue Capital and entered into a $11.5 million loan agreement with an insider-led investor group
Conference call scheduled for 4:30 p.m. ET today...
$Beyond Air (XAIR.US)$
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Beyond Cancer presented promising preclinical data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) therapy at SITC 2024. The study showed that LV UNO combined with anti-rPD-L1 doubled tumor growth inhibition and improved survival in MAT B III tumor-bearing rats compared t...
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Beyond Cancer presented promising preclinical data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) therapy at SITC 2024. The study showed that LV UNO combined with anti-rPD-L1 doubled tumor growth inhibition and improved survival in MAT B III tumor-bearing rats compared t...
$Beyond Air (XAIR.US)$ I am holding this one, it looks like good earnings coming up 11/11 🚀🚀🚀🚀🚀
No comment yet
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
This_Guy : wow
Trytosaveabit OP This_Guy : I know right!
151787202 : source?
Trytosaveabit OP 151787202 : Source of what! That’s from REUTERS!
151787202 Trytosaveabit OP : my bad
View more comments...